The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonistsYumeng Miao, Zhifeng Wei, Yun Zheng et al.|Theranostics|2021Cited by 61
Bergenin, a PPARγ agonist, inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysisLing Yang, Zhifeng Wei, Yun Zheng et al.|Acta Pharmacologica Sinica|2021Cited by 45
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized TrialXiang Li, Jing-Bo Wu, Jinfeng Rong et al.|International Journal of Radiation Oncology*Biology*Physics|2023Cited by 34
Morin inhibits the transformation of fibroblasts towards myofibroblasts through regulating “PPAR-γ-glutaminolysis-DEPTOR” pathway in pulmonary fibrosisYumeng Miao, Zhifeng Wei, Yanzhi Geng et al.|The Journal of Nutritional Biochemistry|2021Cited by 18
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trialYichuan Yuan, Xiaozhong Peng, Wei He et al.|癌症：英文版|2024Cited by 8